Skip to main content

Table 2 Distribution of genotypes and allele frequencies

From: The impact of ABCB1, CYP3A4/5 and ABCG2 gene polymorphisms on rivaroxaban trough concentrations and bleeding events in patients with non-valvular atrial fibrillation

Gene

SNP

Genotype

n (%)

Allele

n (%)

Hardy–Weinberg equilibrium, p value

ABCB1

rs1045642

AA

15 (15.8)

A

80 (42.1)

0.438

  

AG

50 (52.6)

G

110 (57.9)

 
  

GG

30 (31.6)

   
 

rs1128503

AA

35 (36.8)

A

120 (63.2)

0.202

  

AG

50 (52.6)

G

70 (36.8)

 
  

GG

10 (10.5)

   
 

rs4148738

CC

15 (15.8)

C

81 (42.6)

0.342

  

CT

51 (53.7)

T

109 (57.4)

 
  

TT

29 (30.5)

   
 

rs4728709

GG

66 (72.5)

G

155 (85.2)

0.998

  

GA

23 (25.3)

A

27 (14.8)

 
  

AA

2 (2.2)

   

CYP3A4

rs2242480

CC

39 (42.8)

C

123 (67.6)

0.220

  

CT

45 (49.4)

T

59 (32.4)

 
  

TT

7 (7.7)

   
 

rs4646437

GG

60 (65.9)

G

148 (813)

0.903

  

AG

28 (30.8)

A

34 (18.7)

 
  

AA

3 (3.3)

   

CYP3A5

rs776746

TT

7 (8.0)

T

54 (30.7)

0.520

  

TC

40 (45.4)

C

122 (69.3)

 
  

CC

41 (46.6)

   

ABCG2

rs2231137

CC

42 (46.2)

C

125 (68.7)

0.652

  

TC

41 (45.0)

T

57 (31.3)

 
  

TT

8 (8.8)

   
 

rs2231142

GG

45 (49.4)

G

127 (69.8)

0.732

  

GT

37 (40.6)

T

55 (30.2)

 
  

TT

9 (9.9)